Page last updated: 2024-09-05

tak 779 and Osteogenic Sarcoma

tak 779 has been researched along with Osteogenic Sarcoma in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
den Hollander, LS; Dogan, B; Heitman, LH; Hsiao, YY; IJzerman, AP; Lenselink, EB; Openy, J; Ortiz Zacarías, NV; van Veldhoven, JPD	1

Other Studies

1 other study(ies) available for tak 779 and Osteogenic Sarcoma

Article	Year
Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5. Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24 Topics: Antineoplastic Agents; Binding Sites; Bone Neoplasms; Cell Proliferation; Humans; Ligands; Molecular Structure; Osteosarcoma; Protein Binding; Purines; Radioligand Assay; Receptors, CCR2; Receptors, CCR5; Structure-Activity Relationship; Tumor Cells, Cultured	2019

Article

Year

Synthesis and Pharmacological Evaluation of Triazolopyrimidinone Derivatives as Noncompetitive, Intracellular Antagonists for CC Chemokine Receptors 2 and 5.

Journal of medicinal chemistry, 2019, 12-26, Volume: 62, Issue:24

Topics: Antineoplastic Agents; Binding Sites; Bone Neoplasms; Cell Proliferation; Humans; Ligands; Molecular Structure; Osteosarcoma; Protein Binding; Purines; Radioligand Assay; Receptors, CCR2; Receptors, CCR5; Structure-Activity Relationship; Tumor Cells, Cultured

2019